Patents by Inventor Murielle M. Ellison

Murielle M. Ellison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGF-21 mutants comprising polyethylene glycol and uses thereof
    Patent number: 9279013
    Abstract: The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides comprising extended in vivos half-lives, pharmaceutical compositions comprising FGF21 mutant polypeptides having extended in vivos half lives, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: March 8, 2016
    Assignee: Amgen Inc.
    Inventors: Kenneth W. Walker, Colin V. Gegg, Jr., Randy I. Hecht, Edward J. Belouski, Yue-Sheng Li, Mark L. Michaels, Jing Xu, Murielle M. Ellison
  • FGF21 MUTANTS AND USES THEREOF
    Publication number: 20110195895
    Abstract: The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
    Type: Application
    Filed: October 8, 2009
    Publication date: August 11, 2011
    Applicant: Amgen Inc.
    Inventors: Kenneth W. Walker, Colin V. Gegg, JR., Randy I. Hecht, Edward J. Belousky, Yue-Sheng Li, Mark L. Michaels, Jing Xu, Murielle M. Ellison